We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$33.6B
AUM Growth
+$830M
Cap. Flow
-$38.3M
Cap. Flow %
-0.11%
Top 10 Hldgs %
41.94%
Holding
300
New
11
Increased
67
Reduced
100
Closed
13

Top Buys

Rank Stock Value
1
ASML icon
ASML
ASML
+$496M
2
NOW icon
ServiceNow
NOW
+$36.4M
3
SOC icon
Sable Offshore Corp
SOC
+$35.4M
4
AMZN icon
Amazon
AMZN
+$29.4M
5
ZTS icon
Zoetis
ZTS
+$28.6M

Sector Composition

Rank Sector Weight
1 Technology 25.84%
2 Financials 17.64%
3 Healthcare 13.27%
4 Consumer Staples 11.81%
5 Energy 11.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
26
Abbott
ABT
$183B
$458M 1.36%
4,029,287
-2,921
-0.1% -$335K
PGR icon
27
Progressive
PGR
$123B
$447M 1.33%
2,160,449
-6,683
-0.3% -$1.24M
CP icon
28
Canadian Pacific Kansas City
CP
$78.1B
$361M 1.08%
4,096,683
-168,602
-4% -$14.2M
ISRG icon
29
Intuitive Surgical
ISRG
$127B
$353M 1.05%
885,650
+54,700
+7% +$20.7M
ABBV icon
30
AbbVie
ABBV
$443B
$351M 1.04%
1,925,124
-8,122
-0.4% -$1.4M
CMCSA icon
31
Comcast
CMCSA
$85B
$321M 0.96%
7,406,000
-257,698
-3% -$11.1M
MAR icon
32
Marriott International
MAR
$98.3B
$318M 0.95%
1,260,751
+1,897
+0.2% +$459K
ICE icon
33
Intercontinental Exchange
ICE
$85.6B
$296M 0.88%
2,152,558
-7,972
-0.4% -$1.06M
MDLZ icon
34
Mondelez International
MDLZ
$79.5B
$294M 0.87%
4,193,018
-533,569
-11% -$38.9M
MRK icon
35
Merck
MRK
$322B
$291M 0.87%
2,203,596
-209,455
-9% -$25.8M
ADP icon
36
Automatic Data Processing
ADP
$106B
$290M 0.86%
1,160,672
+2,333
+0.2% +$570K
APD icon
37
Air Products & Chemicals
APD
$65.7B
$284M 0.85%
1,173,581
+7,332
+0.6% +$1.8M
META icon
38
Meta Platforms (Facebook)
META
$1.42T
$269M 0.8%
553,697
-100,426
-15% -$44.8M
MO icon
39
Altria Group
MO
$114B
$268M 0.8%
6,148,565
-242,838
-4% -$10.1M
CB icon
40
Chubb
CB
$135B
$265M 0.79%
1,021,273
-2,457
-0.2% -$604K
CME icon
41
CME Group
CME
$96.3B
$245M 0.73%
1,139,063
+31,594
+3% +$6.64M
ADBE icon
42
Adobe
ADBE
$99.5B
$239M 0.71%
474,372
+12,386
+3% +$7.1M
LLY icon
43
Eli Lilly
LLY
$1.02T
$238M 0.71%
306,469
+1,072
+0.4% +$763K
BRK.A icon
44
Berkshire Hathaway Class A
BRK.A
$1.1T
$237M 0.71%
373
-4
-1% -$2.38M
RTX icon
45
RTX Corp
RTX
$290B
$230M 0.68%
2,356,425
+6,554
+0.3% +$592K
SHW icon
46
Sherwin-Williams
SHW
$82.7B
$224M 0.67%
644,706
-873
-0.1% -$278K
LIN icon
47
Linde
LIN
$221B
$204M 0.61%
439,828
-1,110
-0.3% -$481K
AZN icon
48
AstraZeneca
AZN
$263B
$203M 0.6%
1,495,117
+67,392
+5% +$8.92M
NKE icon
49
Nike
NKE
$61.9B
$201M 0.6%
2,136,423
+11,044
+0.5% +$1.12M
COP icon
50
ConocoPhillips
COP
$147B
$196M 0.58%
1,539,921
-6,298
-0.4% -$718K

Similar funds

Fayez Sarofim & Co's Q1 2024 Portfolio in Review

As of Q1 2024, Fayez Sarofim & Co held 300 positions worth $33.6B, up 2.5% from $32.7B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Fayez Sarofim & Co's Q1 2024 filing shows 11 new, 67 increased, 100 reduced and 13 closed positions. Its largest new stake was ASML: 559,224 shares worth $543M. The largest sale was Philip Morris, an estimated $186M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

  • Fayez Sarofim & Co's largest Q1 2024 buy was ASML: 559,224 shares worth $543M.
  • Fayez Sarofim & Co added most to ServiceNow in Q1 2024, an estimated $36.4M increase.
  • Fayez Sarofim & Co's biggest Q1 2024 reduction was Philip Morris, cutting an estimated $186M.
  • Fayez Sarofim & Co fully exited iShares Core High Dividend ETF in Q1 2024, selling an estimated $4.23M.
  • Fayez Sarofim & Co's ten largest holdings make up 42% of its $33.6B portfolio in Q1 2024.
  • Fayez Sarofim & Co opened 11 new positions and closed 13 in Q1 2024.
  • Fayez Sarofim & Co's portfolio value rose 2.5% quarter-over-quarter to $33.6B.

Based on Fayez Sarofim & Co's 13F filing for Q1 2024, filed 14 May 2024.